Kow L-M, Commons K G, Ogawa S, Pfaff D W
The Rockefeller University, Laboratory of Neurobiology and Behavior, 1230 York Avenue, Box 336, New York, NY 10021-6399, USA.
Brain Res. 2002 May 10;935(1-2):87-102. doi: 10.1016/s0006-8993(02)02532-5.
Several lines of evidence have suggested that mu-opioids, generally regarded as inhibitory, also have effects that stimulate neural activity. To look for possible excitatory opioid action in the rat periaqueductal gray (PAG), we first re-examined data from a previous study and found that met-enkephalin could evoke a delayed, sluggish excitation, suggestive of modulation by the opioid on the action of certain excitants. This observation, coupled with other studies that show mu-opioids can modulate NMDA receptor activation, prompted us to perform extracellular recording of the responses of single ventrolateral PAG (vlPAG) neurons in brain slices to DAMGO, a mu-opioid, and to NMDA. When applied alone, DAMGO at nM concentrations, like met-enkephalin, often evoked the delayed excitation and occasionally an inhibition. When applied after a brief exposure to NMDA, DAMGO at doses as low as 0.1 nM potentiated the excitation produced by a subsequent pulse of NMDA. This occurred, depending on cell type, in 23-100% of vlPAG neurons. The potentiating action of DAMGO was blocked by naloxone, suggesting it was mediated by mu-opioid receptors. Characterization of these mu-opioid actions revealed that the potentiation and the delayed excitation, unlike the inhibition, was not blocked by another opioid antagonist, nalmefene, nor by an inhibitor of the G protein of the G(i) class, N-ethylmaleimide. Moreover, the potentiating action was distinct from the inhibition in that it was: (a) enhanced by repeated opioid applications, (b) exhibited low effective doses, (c) had a long time course (minutes to develop and last tens of minutes) and (d) was present in distinct though overlapping cell populations. These data reveal an unconventional action of opioids in PAG neurons, that is, a potentiation of excitation produced by NMDA. This effect appeared mechanistically distinct from opioid inhibition or disinhibition and may be related to established examples of direct opioid excitation. These observations may help understanding behaviorally important mechanisms linked to acute and chronic opioid functions in the vlPAG.
多项证据表明,通常被认为具有抑制作用的μ-阿片类物质也具有刺激神经活动的作用。为了在大鼠中脑导水管周围灰质(PAG)中寻找可能的兴奋性阿片类作用,我们首先重新审视了先前一项研究的数据,发现甲硫氨酸脑啡肽可引发延迟、迟缓的兴奋,提示阿片类物质对某些兴奋性物质的作用具有调节作用。这一观察结果,再加上其他显示μ-阿片类物质可调节NMDA受体激活的研究,促使我们对脑片中单个腹外侧PAG(vlPAG)神经元对μ-阿片类物质DAMGO和NMDA的反应进行细胞外记录。单独应用时,纳摩尔浓度的DAMGO与甲硫氨酸脑啡肽一样,常常引发延迟兴奋,偶尔也会引发抑制作用。在短暂暴露于NMDA后应用时,低至0.1 nM的DAMGO剂量可增强随后NMDA脉冲产生的兴奋作用。根据细胞类型不同,这种情况发生在23%至100%的vlPAG神经元中。DAMGO的增强作用被纳洛酮阻断,表明其由μ-阿片受体介导。对这些μ-阿片类作用的特征分析表明,与抑制作用不同,增强作用和延迟兴奋作用不受另一种阿片拮抗剂纳美芬或G(i)类G蛋白抑制剂N-乙基马来酰亚胺的阻断。此外,增强作用与抑制作用的不同之处在于:(a)反复应用阿片类物质可增强该作用,(b)有效剂量低,(c)作用时间长(数分钟产生并持续数十分钟),(d)存在于不同但有重叠的细胞群体中。这些数据揭示了阿片类物质在PAG神经元中的一种非常规作用,即增强NMDA产生的兴奋作用。这种效应在机制上似乎与阿片类抑制作用或去抑制作用不同,可能与已确立的直接阿片类兴奋作用实例有关。这些观察结果可能有助于理解与vlPAG中急性和慢性阿片类功能相关的行为重要机制。